Search Medical Condition
Please enter condition
Please choose location
 

Clermont Ferrand Cedex 1, France Clinical Trials

A listing of Clermont Ferrand Cedex 1, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (19223) clinical trials

Characterize the safety, tolerability, ECG effects, pharmacokinetics and immunogenicity of anetumab ravtansine given as single agent and after inhibition of CYP3A4 and P-gp by concomitant administration of itraconazole in subjects with mesothelin-expressing advanced solid cancers

Phase

Evaluate the potential effect of hepatic or renal impairment on the pharmacokinetics, safety and tolerability of BAY 1841788 (ODM-201).

Phase

This study will be conducted in 2 parts. The phase 1b part will be an international, phase 1b, open-label, dose-escalation assessment of radium-223 dichloride administered with bortezomib and dexamethasone in subjects with relapsed multiple myeloma. The primary endpoint is to determine the optimal dose of radium-223 dichloride in combination with ...

Phase

- This is the first study where BAY1163877 is given to humans. Impact of the study is to evaluate if patients with advanced solid cancers show advanced clinical benefit under the treatment with the pan FGFR inhibitor. Patients (all comers) will receive the study drug treatment in a dose-escalation scheme ...

Phase

The California Clinical Trials Medical Group managed by PAREXEL located in Glendale, CA is looking for people with depression to participate in a research study that will evaluate the efficacy of a new investigational medication for the treatment of depression. The study may involve up to 2 screening visits, 5 ...

Phase

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophrenia

Phase

Children and young adults who have Type 1 Diabetes are invited to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

If you or a family member have cutaneous lupus erythematosus (CLE) and/or systemic lupus erythematosus (SLE), you may want to consider the LILAC clinical research study. What is the purpose of the LILAC study? The purpose of the LILAC study is to learn if an investigational medication may effectively reduce ...

Phase N/A

To determine the maximum tolerated and / or recommended Phase II dose of oral mutant IDH1 (mIDH1) inhibitor BAY1436032 and to characterize its safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy in patients with mIDH1-R132X advanced acute myeloid leukemia (AML)

Phase

To evaluate the pharmacokinetics and safety of copanlisib in subjects with impaired hepatic or renal function in comparison to healthy subjects

Phase